Philip W. Kantoff
Director, Context Therapeutics Inc.
Companies
- Context Therapeutics Inc.Board member Oct 19, 2021 to now1
- Essa Pharma (United States)Board member Sep 21, 2022 to Mar 28, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Context Therapeutics Inc. CNTX3,533 shares3$847 at $0.24Oct 19, 2021
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3